BLOOD PRESSURE AND PLASMA FGF-23 CONCENTRATION CHANGES AFTER CINACALCET TREATMENT IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Adamczak, M. [1 ]
Kuczera, P. [1 ]
Wiecek, A. [1 ]
机构：
[1] Dept Nephrol Transplantol & Internal Med, Katowice, Poland
来源：
JOURNAL OF HYPERTENSION | 2015年 / 33卷
关键词：
D O I：
10.1097/01.hjh.0000468926.58110.3f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.39.14
引用
收藏
页码：E488 / E489
页数：2
相关论文
共 50 条
  • [41] Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism
    Evans, Marie
    Methven, Shona
    Gasparini, Alessandro
    Barany, Peter
    Birnie, Kate
    MacNeill, Stephanie
    May, Margaret T.
    Caskey, Fergus J.
    Carrero, Juan-Jesus
    SCIENTIFIC REPORTS, 2018, 8
  • [42] Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism
    Marie Evans
    Shona Methven
    Alessandro Gasparini
    Peter Barany
    Kate Birnie
    Stephanie MacNeill
    Margaret T. May
    Fergus J. Caskey
    Juan-Jesus Carrero
    Scientific Reports, 8
  • [43] FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis
    Lima, Florence
    El-Husseini, Amr
    Monier-Faugere, Marie-Claude
    David, Valentin
    Mawad, Hanna
    Quarles, Darryl
    Malluche, Hartmut H.
    CLINICAL NEPHROLOGY, 2014, 82 (05) : 287 - 295
  • [44] CHANGES IN FGF-23, KLOTHO, PTH AND SERUM PHOSPHOROUS LEVELS AFTER DIETARY MODIFICATIONS IN CHRONIC KIDNEY DISEASE STAGES 1 AND 2
    Saxena, Anita
    Sachan, Trisha
    Amit, Gupta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [45] Cinacalcet HCl is an effective treatment for secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) not yet receiving dialysis.
    Coburn, JW
    Charytan, C
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, P
    Yahaghi, AS
    Pichette, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 460A - 460A
  • [46] Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
    Ponce, Daniela
    Cardoso, Marilia Mastrocolla de Almeida
    Rugolo, Juliana Rodrigues Machado
    Molina, Silvana Andrea
    Andrade, Luis Gustavo Modelli de
    Curado, Daniel da Silva Pereira
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (03): : 365 - 372
  • [47] High plasma C-terminal FGF-23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury
    Chang, Yu-Hsing
    Wu, Che-Hsiung
    Chou, Nai-Kuan
    Tseng, Li-Jung
    Huang, I-Ping
    Wang, Chih-Hsien
    Wu, Vin-Cent
    Chu, Tzong-Shinn
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2020, 11
  • [48] Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
    Perez-Ricart, Ariadna
    Galicia-Basart, Maria
    Comas-Sugranes, Dolors
    Cruzado-Garrit, Josep-Maria
    Segarra-Medrano, Alfons
    Montoro-Ronsano, Jose-Bruno
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2019, 38 (02) : 229 - 238
  • [49] Efficacy and safety of cinacalcet and active vitamin D in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease: a network meta-analysis
    Ni, Li-Hua
    Yuan, Cheng
    Song, Kai-Yun
    Wang, Xiao-Chen
    Chen, Si-Jie
    Wang, Li-Ting
    Zhang, Yu-Xia
    Liu, Hong
    Liu, Bi-Cheng
    Tang, Ri-Ning
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (14)
  • [50] Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness
    Choi, Hye-Min
    Kwon, Young-Eun
    Kim, Sol
    Oh, Dong-Jin
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05): : 1166 - 1178
12345